Five Things You Didn't Know About Chemotherapy WASHINGTON,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Five Things You Didn't Know About Chemotherapy

WASHINGTON, D.C., June 24, 2014 (GLOBE NEWSWIRE) -- Cancer. Chemotherapy. Infusion. What image just popped into your mind? Maybe a child in a hospital bed, receiving his medicine through a port in his chest, or a young woman with a bright smile proudly showing off her newly shaved head.

We often see images like these associated with cancer treatment and chemotherapy. But what many people don't realize is that each patient's treatment journey is unique; as doctors and scientists become more sophisticated in the fight against cancer, there are increasingly more types of chemotherapy, drugs, dosages and treatment strategies oncologists consider when developing treatment regimens. And all of these are tailored to individuals as breakthroughs move forward at the genetic level.

With the focus on personalized medicine, it's becoming even more important that patients take an active role in their diagnosis. A realistic idea of what chemo entails can help patients and caregivers prepare and advocate effectively. These five chemotherapy myth busters are meant to strike down some of the most common chemo misconceptions. Here's what you need to know:

#1
Myth: You will not be able to work while on chemo.
Fact: Most people work full-time on FOLFOX or FOLFIRI , two common chemo drugs. In fact, many find going to work helps by creating a feeling of normalcy and keeping patients busy and their minds off their cancer. The key to this is proper management of side effects. In certain situations, side effects may make patients very sick, therefore making it difficult to work. An afternoon rest may also help reenergize.

#2
Myth: You will have constant nausea, diarrhea and fatigue.
Fact: Much research has gone into making it easier for patients to remain active during treatment. Medical teams now know how to manage these common side effects. For nausea and diarrhea, treating physicians typically prescribe pre-medications (taken before treatment) and medications to be taken once home. Most physicians recommend managing fatigue with lifestyle choices like exercise, diet and getting plenty of fluids and rest. But, do not suffer in silence. If the current combination of medicines isn't working, tell your medical team so they can adjust.

#3
Myth: You will spend all your time in the hospital.
Fact: There are many ways chemo drugs are administered depending on the patient's needs. Most patients are treated intravenously on an outpatient basis at their local hospital or clinic. However, sometimes patients can be given a simple shot or even pill or liquid to take at home.

#4
Myth: You will lose all of your hair.
Fact: Not all chemotherapy drugs cause hair loss. In fact, even if a patient is on a drug for which this is a side effect, many will experience only a thinning. For those who do experience thinning or total loss, it will grow back after your treatment course is complete, and sometimes even before that.

#5
Myth: Everyone receives the same amount of chemo.
Fact: Every patient is unique and should receive a very specific dose
of chemo. Despite the advances in fighting cancer, it is sometimes a challenge to determine the right dosage a patient should receive for optimal effectiveness.

The Colon Cancer Alliance is committed to supporting and empowering the public about cancer through its ongoing webinar series. Participate in their free webinar happening today in partnership with MyCare Diagnostics to learn more about recent advances that will allow for more personalized treatment and more accurate chemotherapy dosing.

Event Details:
Webinar: Better Cancer Care Through Accurate and Personalized Chemotherapy Dosing
Date: Tuesday, June 24, 2014
Time: 7:00 p.m. – 8:00 p.m. ET
Register here


# # #

The Colon Cancer Alliance's mission is to knock colon cancer out of the top three cancer killers. This mission is being accomplished by championing prevention, funding cutting-edge research and providing the highest quality patient support services. Learn more at ccalliance.org .

Colleen Pyra (949) 554-4098

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 115

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 398

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 303

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

Flow Battery Market Forecasts Strong Growth to $1.18 Billion

Updated Category News Views 156

Understanding the Rising Flow Battery Market The global flow battery market is set to reach USD 1.18 billion by 2030, rising from USD 0.34 billion in 2024, marking a considerable compound annual growth rate (CAGR) of 23.0%. This notable expansion can be attributed to the technology's advantages over traditional energy storage solutions like lithium-ion and lead-acid...

Continue Reading
Reviving the Essence of Pacific Palisades Community Council

Updated Category News Views 189

Pacific Palisades Community Council Initiatives The Pacific Palisades Community Council is embarking on an exciting journey to reclaim the unique character that defines their community. With a firm commitment to working alongside the California Community Foundation, this council is not only focused on enhancing the beauty of the Palisades but also on reinstating the...

Continue Reading
Ares Capital Welcomes Jim Miller as New Co-President

Updated Category News Views 200

Ares Capital Corporation Welcomes New Leadership Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) has recently made significant advancements in its leadership structure by appointing Jim Miller as Co-President. Jim will work alongside the current Co-President, Kort Schnabel, to further the company's strategic objectives. This change reflects Ares Capital's...

Continue Reading
Breda University Discusses Sustainable Holiday Deliveries

Updated Category News Views 271

Sustainable Online Shopping During the Holidays As the holiday season approaches, millions of online purchases will be delivered straight to consumers' homes. This trend is often considered less sustainable than it truly is. According to Hans Quak, a respected Professor specializing in Smart Cities and Logistics at Breda University of Applied Sciences (BUas), the holiday...

Continue Reading
Harley-Davidson's $1.25 Billion Move: A New Era of Growth

Updated Category News Views 127

Harley-Davidson's New Financial Strategy with KKR and PIMCO Recently, Harley-Davidson, Inc. (NYSE: HOG) announced a groundbreaking partnership with two financial giants, KKR and PIMCO. This strategic alliance is poised to unlock approximately $1.25 billion of discretionary capital. The transformation not only simplifies Harley-Davidson Financial Services (HDFS) but also...

Continue Reading